IgG and fibrinogen driven nanoparticle aggregation

Nano Research

Volumn 8, Issue 8, 2015, Pages 2733-2743

  Cukalevski, Risto ^a   Ferreira, Silvia A ^b   Dunning, Christopher J ^a,c   Berggård, Tord ^d   Cedervall, Tommy ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF MINHO   (Portugal)

^c LUND UNIVERSITY   (Sweden)

^d Alligator Bioscience   (Sweden)

Author keywords

aggregation; corona; immunoglobulin; nanoparticles (NPs); protein

Indexed keywords

EID: 84939267321     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-015-0780-4     Document Type: Article

References (34)

1. Sund, J.; Alenius, H.; Vippola, M.; Savolainen, K.; Puustinen, A. Proteomic characterization of engineered nanomaterialprotein interactions in relation to surface reactivity. ACS Nano2011, 5, 4300–4309.
2. Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.; Cingolani, R.; Pompa, P. P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano2010, 4, 7481–7491.
3. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA2008, 105, 14265–14270.
4. Ferreira, S. A.; Oslakovic, C.; Cukalevski, R.; Frohm, B.; Dahlback, B.; Linse, S.; Gama, F. M.; Cedervall, T. Biocompatibility of mannan nanogel-safe interaction with plasma proteins. Biochim. Biophys. Acta2012, 1820, 1043–1051.
5. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnology, Biology, and Medicine2009, 5, 106–117.
6. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA2007, 104, 2050–2055.
7. Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem., Int. Ed.2007, 46, 5754–5756.
8. Walkey, C. D.; Olsen, J. B.; Guo, H.; Emili, A.; Chan, W. C. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc.2012, 134, 2139–2147.
9. Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A.; Knauer, S. K.; Bantz, C.; Nawroth, T.; Bier, C.; Sirirattanapan, J. et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACS Nano2011, 5, 7155–7167.
10. Dell’Orco, D.; Lundqvist, M.; Oslakovic, C.; Cedervall, T.; Linse, S. Modeling the time evolution of the nanoparticleprotein corona in a body fluid. PloS One2010, 5, e10949.
11. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano2010, 4, 3623–3632.
12. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc.2011, 133, 2525–2534.
13. Shang, W.; Nuffer, J. H.; Muniz-Papandrea, V. A.; Colon, W.; Siegel, R. W.; Dordick, J. S. Cytochrome C on silica nanoparticles: Influence of nanoparticle size on protein structure, stability, and activity. Small2009, 5, 470–476.
14. Shang, W.; Nuffer, J. H.; Dordick, J. S.; Siegel, R. W. Unfolding of ribonuclease A on silica nanoparticle surfaces. Nano Lett.2007, 7, 1991–1995.
15. Lundqvist, M.; Sethson, I.; Jonsson, B. H. Protein adsorption onto silica nanoparticles: Conformational changes depend on the particles’ curvature and the protein stability. Langmuir2004, 20, 10639–10647.
16. Pitek, A. S.; O’Connell, D.; Mahon, E.; Monopoli, M. P.; Baldelli Bombelli, F.; Dawson, K. A. Transferrin coated nanoparticles: Study of the bionano interface in human plasma. PloS One2012, 7, e40685.
17. Cukalevski, R.; Lundqvist, M.; Oslakovic, C.; Dahlback, B.; Linse, S.; Cedervall, T. Structural changes in apolipoproteins bound to nanoparticles. Langmuir2011, 27, 14360–14369.
18. Jiang, X.; Jiang, J. G.; Jin, Y. D.; Wang, E.; Dong, S. J. Effect of colloidal gold size on the conformational changes of adsorbed cytochrome C: Probing by circular dichroism, UV-visible, and infrared spectroscopy. Biomacromolecules2005, 6, 46–53.
19. Goy-Lopez, S.; Juarez, J.; Alatorre-Meda, M.; Casals, E.; Puntes, V. F.; Taboada, P.; Mosquera, V. Physicochemical characteristics of protein-NP bioconjugates: The role of particle curvature and solution conditions on human serum albumin conformation and fibrillogenesis inhibition. Langmuir2012, 28, 9113–9126.
20. Dominguez-Medina, S.; McDonough, S.; Swanglap, P.; Landes, C. F.; Link, S. In situ measurement of bovine serum albumin interaction with gold nanospheres. Langmuir2012, 28, 9131–9139.
21. Glomm, W. R.; Halskau, Ø.; Hanneseth, A. M.; Volden, S. Adsorption behavior of acidic and basic proteins onto citrate-coated Au surfaces correlated to their native fold, stability, and pI. J. Phys. Chem. B2007, 111, 14329–14345.
22. Zhang, D. M.; Neumann, O.; Wang, H.; Yuwono, V. M.; Barhoumi, A.; Perham, M.; Hartgerink, J. D.; Wittung-Stafshede, P.; Halas, N. J. Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH. Nano Lett.2009, 9, 666–671.
23. Kumar, S.; Aswal, V. K.; Kohlbrecher, J. SANS and UV-vis spectroscopy studies of resultant structure from lysozyme adsorption on silica nanoparticles. Langmuir2011, 27, 10167–10173.
24. Gagner, J. E.; Lopez, M. D.; Dordick, J. S.; Siegel, R. W. Effect of gold nanoparticle morphology on adsorbed protein structure and function. Biomaterials2011, 32, 7241–7252.
25. Bharti, B.; Meissner, J.; Findenegg, G. H. Aggregation of silica nanoparticles directed by adsorption of lysozyme. Langmuir2011, 27, 9823–9833.
26. Kendall, M.; Ding, P.; Kendall, K. Particle and nanoparticle interactions with fibrinogen: The importance of aggregation in nanotoxicology. Nanotoxicology2011, 5, 55–65.
27. Deng, Z. J.; Liang, M.; Toth, I.; Monteiro, M. J.; Minchin, R. F. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano2012, 6, 8962–8969.
28. 3 and ZnO nanoparticles. Nanotoxicology2012, 6, 837–846.
29. Wiogo, H. T.; Lim, M.; Bulmus, V.; Yun, J.; Amal, R. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir2011, 27, 843–850.
30. Wiogo, H. T.; Lim, M.; Bulmus, V.; Gutierrez, L.; Woodward, R. C.; Amal, R. Insight into serum protein interactions with functionalized magnetic nanoparticles in biological media. Langmuir2012, 28, 4346–4356.
31. Zook, J. M.; Maccuspie, R. I.; Locascio, L. E.; Halter, M. D.; Elliott, J. T. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology2011, 5, 517–530.
32. 2) nanoparticles. Small2011, 7, 3479–3486.
33. Oslakovic, C.; Cedervall, T.; Linse, S.; Dahlback, B. Polystyrene nanoparticles affecting blood coagulation. Nanomedicine: Nanotechnology, Biology, and Medicine2012, 8, 981–986.
34. Ferreira, S. A.; Pereira, P.; Sampaio, P.; Coutinho, P. J. G.; Gama, F. M. Supramolecular assembled nanogel made of mannan. J. Colloid Interf. Sci.2011, 361, 97–108.